Absci (ABSI) Accounts Payables (2020 - 2026)
Absci (ABSI) posted Accounts Payables of $17.3 million for Q1 2026, down 10.53% sequentially from $19.3 million in Q4 2025, and up 249.91% YoY from $4.9 million in Q1 2025.
Absci (ABSI) Accounts Payables (2020 - 2026) Analysis & Trends
Absci has reported Accounts Payables for 7 years, with the latest figure at $17.3 million in Q1 2026.
- Quarterly Accounts Payables rose 249.91% year-over-year to $17.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.3 million (up 249.91% YoY) and the FY2025 annual result came in at $19.3 million, up 85.17% from the prior year.
- Accounts Payables declined to $17.3 million in Q1 2026 per ABSI's latest filing, from $19.3 million in the prior quarter.
- Over five years, Accounts Payables peaked at $19.3 million in Q4 2025 and troughed at $1.5 million in Q4 2023.
- A 5-year average of $5.5 million and a median of $2.4 million in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables sank 71.32% in 2023, then soared 595.21% in 2024.
- Over 5 years, Accounts Payables stood at $2.4 million in 2022, then tumbled by 37.69% to $1.5 million in 2023, then jumped by 595.21% to $10.4 million in 2024, then jumped by 85.17% to $19.3 million in 2025, then declined by 10.53% to $17.3 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $17.3 million, $19.3 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | 16.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.26 Mn |
| Mar 31, 2026 | 17.31 Mn |
| Dec 31, 2025 | 19.35 Mn |
| Sep 30, 2025 | 4.59 Mn |
| Jun 30, 2025 | 8.21 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | 10.45 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.85 Mn |
| Mar 31, 2023 | 1.93 Mn |
| Dec 31, 2022 | 2.41 Mn |
| Sep 30, 2022 | 1.86 Mn |
| Jun 30, 2022 | 5.47 Mn |
| Mar 31, 2022 | 6.74 Mn |
| Dec 31, 2021 | 8.39 Mn |
| Sep 30, 2021 | 6.37 Mn |